SONTRA MEDICAL

Sontra Medical Corporation owns technology in ultrasound and skin permeation methods used in transdermal science for therapeutic and diagnostic applications, and are developing a non-invasive CTGM for use in the large diabetes home use and hospital intensive and critical care markets. Sontra's CTGM device leverages its FDA-approved SonoPrep(R) ultrasound-mediated skin permeation system.